GlassScriptPhysician profile
Alexander Lister
NPI 1649732769
$1,714.85
in general payments reported to CMS, 2019-2025
12 companies · $15.54 in 2025
The $15.54 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $170 · 2021: $375 · 2022: $571 · 2023: $104 · 2024: $346 · 2025: $15.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $547.49 | 2020-2024 | Augment Injectable, Infinity |
| Smith+Nephew, INC. | $546.32 | 2020-2023 | Pico |
| Zimmer Biomet Holdings, INC. | $133.79 | 2019 | |
| Treace Medical Concepts, INC. | $130.65 | 2024-2025 | |
| Nevro Corp. | $128.56 | 2022 | |
| Integra Lifesciences Corporation | $70.55 | 2021-2022 | |
| Biotissue Holdings INC. | $56.99 | 2021-2023 | |
| Alfasigma USA, INC. | $31.66 | 2022 | |
| Next Science LLC | $24.05 | 2022 | |
| Grt US Holding, INC. | $20.15 | 2022 | |
| Depuy Synthes Sales INC. | $13.19 | 2020 | |
| Hartmann USA, INC. | $11.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Lister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.